Pictet Asset Management
EWTX icon

Pictet Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Pictet Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Sell
6,280
-1,343
-18% -$46.3K ﹤0.01% 1855
2026
Q1 		$240K Buy
+7,623
New +$220K ﹤0.01% 1843
2025
Q2 		– Sell
-302,513
Closed -$6.66M – 2020
2025
Q1 		$6.66M Buy
302,513
+1,272
+0.4% +$33.4K 0.01% 749
2024
Q4 		$8.04M Buy
+301,241
New +$9.59M 0.01% 721

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pictet Asset Management's EWTX Position: Q2 2026 in Review

Pictet Asset Management reduced its Edgewise Therapeutics (EWTX) stake by 18% in Q2 2026, selling an estimated $46.3K and leaving 6,280 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Pictet Asset Management first reported a position in EWTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $8.04M in Q4 2024. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Pictet Asset Management held 6,280 shares of Edgewise Therapeutics worth $255K as of Q2 2026.
  • Pictet Asset Management sold 1,343 Edgewise Therapeutics shares in Q2 2026, an estimated $46.3K.
  • Edgewise Therapeutics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1855 holding.
  • Pictet Asset Management first reported a position in Edgewise Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Pictet Asset Management's Edgewise Therapeutics position peaked at $8.04M in Q4 2024.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.